A: The Oyikey SMGT GLP-1 Microneedle Patch is a product marketed online as a painless, long-lasting treatment for obesity, diabetes, and cardiovascular disease
Knowing what a Retatrutide 4mg dose actually represents, and why that context does not carry over into personal use, helps make sense of a number that gets discussed frequently without much explanation
Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss
The timing of symptoms often follows a predictable pattern
You have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
It is not suitable for use during pregnancy, while planning to become pregnant, or while breastfeeding